
May 13, 2022
Welcoming Ashwin Somasundaram
We’re proud to announce Ashwin Somasundaram, MD, as the newest member of the UNC Lineberger Pancreatic Cancer Center of Excellence (PCCE).
May 13, 2022
We’re proud to announce Ashwin Somasundaram, MD, as the newest member of the UNC Lineberger Pancreatic Cancer Center of Excellence (PCCE).
May 6, 2022
UNC Lineberger's Ralph Baric, PhD, and Jenny P. Ting, PhD, have been elected to the American Academy of Arts and Sciences. They join seven other UNC Lineberger members with this honor.
March 24, 2022
Yevgeny Brudno, PhD, and colleagues from NC State University and UNC-Chapel Hill have developed an implantable biotechnology that produces and releases CAR-T for attacking cancerous tumors.
January 11, 2022
Yuliya Pylayeva-Gupta, PhD, is a recipient of The Mark Foundation for Cancer Research Emerging Leader Award. The funding will support her research focused on reprogramming B cell fate and function in cancer.
October 13, 2021
Susan G. Komen has awarded three grants in support of metastatic breast cancer research as part of a collaboration between Komen, UNC Lineberger and Duke Cancer Institute, called the Susan G. Komen Metastatic Breast Cancer Collaborative Research Initiative.
October 6, 2021
Researchers from UNC Lineberger and colleagues report pairing a newly developed gel with immunotherapy that was delivered to post-surgical lab models with glioblastoma improved the immunotherapy’s effectiveness.
September 10, 2021
Josh Zeidner, MD, Jon Serody, MD, and colleagues report clinical trial outcomes that benefited patients with resistant or relapsed acute myeloid leukemia.
June 22, 2021
Jenny P. Ting, PhD, is being honored for her outstanding discoveries in the fields of immunology, molecular biology, genomics, and microbiology.
December 31, 2020
CAR-T therapy has proven effective for some blood cancers. New research by Jonathan S. Serody, MD, and colleagues suggests ways to use it effectively to attack solid tumors.
November 22, 2020